Author

S. Day

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Biochemistry· 1 Bioengineering· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 8 Organism:human· 6 Assay:proteomics· 5 Research Focus:cell type annotation· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

A. Trivette· 4 shared E. Binshtein· 4 shared E. C. Chen· 4 shared J. E. Crowe· 4 shared L. Myers· 4 shared P. Gilchuk· 4 shared R. E. Sutton· 4 shared R. H. Carnahan· 4 shared

Activity by Year

2019-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. Trivette

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes

E. C. Chen, P. Gilchuk, S. J. Zost, P. A. Ilinykh, E. Binshtein, K. Huang, L. Myers, S. Bonissone, S. Day, C. R. Kona, A. Trivette, J. X. Reidy, R. E. Sutton, C. Gainza, S. Monroig, , J. E. Crowe

The paper analyzes the human antibody response to ebolavirus glycoprotein, identifying public clonotypes with neutralizing activity and implications for vaccine design.

bioRxiv · Jan 12, 2022 · PreprintImmunology

Metabolic and Proteomic Defects in Human Hypertrophic Cardiomyopathy

M. Previs, T. O'Leary, N. Wood, M. Morley, B. Palmer, M. LeWinter, J. Yob, F. Pagani, C. Petucci, M. S. Kim, K. Margulies, Z. Arany, D. Kelly, S. Day

This study identifies metabolic and proteomic defects in human hypertrophic cardiomyopathy, showing depletion of fatty acid derivatives and increased alternate fuel metabolites.

bioRxiv · Aug 18, 2021 · PreprintPhysiology

Sirtuin 5 levels are limiting in preserving cardiac function and suppressing fibrosis in response to pressure overload

A. H. Guo, R. K. Baliira, M. E. Skinner, S. Kumar, A. Andren, L. Zhang, S. Michan, N. J. Davis, M. W. Maccani, S. Day, D. A. Sinclair, C. A. Lyssiotis, A. B. Stein, D. B. Lombard

This study shows that overexpressing SIRT5 protects against cardiac dysfunction and fibrosis in response to pressure overload in mice.

bioRxiv · Jun 15, 2021Pathology

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

E. C. Chen, P. Gilchuk, S. J. Zost, N. Suryadevara, E. S. Winkler, C. R. Cabel, E. Binshtein, R. E. Sutton, J. L. Rodriguez, S. Day, L. Myers, A. Trivette, J. K. Williams, E. Davidson, S. Li, , J. E. Crowe

The paper identifies public antibody clonotypes in SARS-CoV-2 convalescents and vaccinated individuals, revealing common epitope recognition and potential vaccine efficacy mechanisms.

bioRxiv · May 2, 2021Immunology

3D-Printing and upper-limb prosthetic sockets; promises and pitfalls

J. Olsen, S. Day, S. Dupan, K. Nazarpour, M. Dyson

This paper evaluates the feasibility of using 3D scanning and printing for low-cost trans-radial prosthetic sockets, highlighting the need for clinical expertise to ensure success.

bioRxiv · Sep 21, 2020Bioengineering

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

S. J. Zost, P. Gilchuk, J. B. Case, E. Binshtein, R. E. Chen, J. X. Reidy, A. Trivette, R. S. Nargi, R. E. Sutton, N. Suryadevara, L. E. Williamson, E. C. Chen, T. Jones, S. Day, L. Myers, , J. E. Crowe

The paper identifies potent neutralizing antibodies against SARS-CoV-2 that block receptor binding and protect animals, providing insights for vaccine and therapy development.

bioRxiv · May 22, 2020Immunology

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

S. J. Zost, P. Gilchuk, R. Chen, J. B. Case, J. X. Reidy, A. Trivette, R. S. Nargi, R. E. Sutton, N. Suryadevara, E. C. Chen, E. Binshtein, S. Shrihari, M. A. Ostrowski, H. Y. Chu, J. E. Didier, , J. E. Crowe

This study isolates and profiles human monoclonal antibodies against SARS-CoV-2 spike protein, identifying neutralizing antibodies targeting the receptor-binding domain.

bioRxiv · May 12, 2020Immunology

Signature activities of 20S proteasome include degradation of the ubiquitin-tag with the protein under hypoxia

I. Sahu, S. M. Mali, P. Sulkshane, A. Rozenberg, C. Xu, R. Morag, M. P. Sahoo, S. K. Singh, Z. Ding, Y. Wang, S. Day, Y. Cong, O. Kleifeld, A. Brik, M. H. Glickman

The paper identifies the 20S proteasome's ability to degrade ubiquitin-tagged proteins under hypoxia and shows its role in improving cell survival.

bioRxiv · Dec 20, 2019 · PreprintBiochemistry